11 May 2016
What do you get from your subscription?
10 year forecasts
View Datamonitor Healthcare’s 10-year patient based forecasts for key immunology indications, including the impact of the first lupus approval in 50+ years and novel oral products
Gain an in-depth understanding of key treatment trends and prescribing patterns, with insight from surveys of rheumatologists and dermatologists in the US, Japan, and five major EU markets
Examine patient populations, 10 year incident case forecasts and patient segments to recognize market potential
Pipeline and marketed drugs
Understand how companies are looking to differentiate their products to stay competitive in the immunology markets and what threats are faced by current market leaders